Suchergebnisse - "Allegretti, Jessica R"

PubPharm (8)

1

1-Year Comparative Effectiveness of Tofacitinib vs Ustekinumab for Patients With Ulcerative Colitis and Prior Antitumor Necrosis Factor Failure

enthalten in: Inflammatory bowel diseases | 2024

von Dalal, R. | Sharma, P. | Bains, K. | +2

2

Reply : Tofacitinib in Ulcerative Colitis: Beyond Biologics?

enthalten in: Inflammatory bowel diseases | 2024

von Dalal, R. | Allegretti, J.

CommentOn: Inflamm Bowel Dis. 2023 Oct 16;:. - PMID 37843044

3

Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain

enthalten in: Journal of gastroenterology and hepatology | 2024

von Allegretti, J. | Gecse, K. | Chiorean, M. | +8

4

Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program

enthalten in: The patient | 2023

von Hudesman, D. | Torres, J. | Salese, L. | +5

5

Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore

enthalten in: BMC gastroenterology | 2023

von Lee, S. | Allegretti, J. | Steinwurz, F. | +4

6

Tofacitinib for the Treatment of Pouch-Related Disorders : A Case Series

enthalten in: Inflammatory bowel diseases | 2022

von Dalal, R. | Bains, K. | Marcus, J. | +2

7

Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis

enthalten in: BMC gastroenterology | 2022

von Chiorean, M. | Allegretti, J. | Sharma, P. | +7

ErratumIn: BMC Gastroenterol. 2022 Jul 26;22(1):356. - PMID 35883049

8

Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis : A Propensity Score Analysis

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

1
[1]